KR20160023762A - Lactobacillus plantarum K46 and composition comprising the same - Google Patents
Lactobacillus plantarum K46 and composition comprising the same Download PDFInfo
- Publication number
- KR20160023762A KR20160023762A KR1020160019926A KR20160019926A KR20160023762A KR 20160023762 A KR20160023762 A KR 20160023762A KR 1020160019926 A KR1020160019926 A KR 1020160019926A KR 20160019926 A KR20160019926 A KR 20160019926A KR 20160023762 A KR20160023762 A KR 20160023762A
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- lactobacillus plantarum
- composition
- kacc91758p
- lactobacillus
- Prior art date
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 50
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 39
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- 244000005700 microbiome Species 0.000 claims abstract description 15
- 239000000654 additive Substances 0.000 claims abstract description 9
- 230000000996 additive effect Effects 0.000 claims abstract description 8
- 239000004460 silage Substances 0.000 claims description 24
- 230000003078 antioxidant effect Effects 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 230000003064 anti-oxidating effect Effects 0.000 claims description 4
- 241000228150 Penicillium chrysogenum Species 0.000 claims description 3
- 240000000064 Penicillium roqueforti Species 0.000 claims description 3
- 241000228193 Aspergillus clavatus Species 0.000 claims description 2
- 240000006439 Aspergillus oryzae Species 0.000 claims description 2
- 241000228212 Aspergillus Species 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 241000272525 Anas platyrhynchos Species 0.000 claims 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 abstract description 24
- 244000144972 livestock Species 0.000 abstract description 6
- 235000019629 palatability Nutrition 0.000 abstract description 4
- 235000019621 digestibility Nutrition 0.000 abstract description 3
- 230000001965 increasing effect Effects 0.000 abstract description 3
- 241000186610 Lactobacillus sp. Species 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 19
- 230000000843 anti-fungal effect Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000000529 probiotic effect Effects 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 11
- 239000008272 agar Substances 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000006041 probiotic Substances 0.000 description 9
- 235000018291 probiotics Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 108020004465 16S ribosomal RNA Proteins 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 241000186660 Lactobacillus Species 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 7
- 229940121375 antifungal agent Drugs 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 241001225321 Aspergillus fumigatus Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000233732 Fusarium verticillioides Species 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229940039696 lactobacillus Drugs 0.000 description 5
- 239000006872 mrs medium Substances 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- 230000002949 hemolytic effect Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
- 229940035901 lactobacillus sp Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000011392 neighbor-joining method Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000223211 Curvularia lunata Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 102000019199 alpha-Mannosidase Human genes 0.000 description 2
- 108010012864 alpha-Mannosidase Proteins 0.000 description 2
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 229940093761 bile salts Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229960004125 ketoconazole Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- NLEPLDKPYLYCSY-UHFFFAOYSA-N 2-fluoroquinoline Chemical compound C1=CC=CC2=NC(F)=CC=C21 NLEPLDKPYLYCSY-UHFFFAOYSA-N 0.000 description 1
- VOXXWSYKYCBWHO-UHFFFAOYSA-N 3-phenyllactic acid Chemical compound OC(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-N 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 101710180684 Beta-hexosaminidase Proteins 0.000 description 1
- 101710124976 Beta-hexosaminidase A Proteins 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 1
- 102000030900 Cystinyl aminopeptidase Human genes 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001459563 Phyllachora graminis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 101710081801 Protein O-GlcNAcase Proteins 0.000 description 1
- 101710199095 Putative beta-hexosaminidase Proteins 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 108010061261 alpha-glucuronidase Proteins 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 238000009635 antibiotic susceptibility testing Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000012474 bioautography Methods 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960001506 brilliant green Drugs 0.000 description 1
- HXCILVUBKWANLN-UHFFFAOYSA-N brilliant green cation Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 HXCILVUBKWANLN-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- -1 lipid peroxides Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 description 1
- 229940046307 sodium thioglycolate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A23K1/009—
-
- A23L1/3014—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- C12R1/25—
-
- A23Y2220/67—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 신규한 락토바실러스 플란타룸 균주 및 이를 포함하는 조성물에 관한 것으로, 더욱 상세하게는 항곰팡이 활성이 우수한 신규한 락토바실러스 플란타룸 균주 및 이를 이용한 품질이 개선된 사일리지에 관한 것이다.The present invention relates to a novel Lactobacillus plantarum strain and a composition comprising the same, and more particularly to a novel Lactobacillus plantarum strain having excellent antifungal activity and a silage with improved quality using the same.
조사료는 일시에 다량 생산되므로 연중 안정적인 급여를 위해서는 저장을 해야 하는데, 수분을 제거한 저장이 건초인 반면 수분이 있는 상태에서 저장을 하는 것이 사일리지(silage)이다. Since the forage is produced in large quantities at a time, it is necessary to store it for stable salary throughout the year. The silage is the storage of moisture while the moisture is removed from the hay.
최근 들어 사일리지의 품질 향상을 위한 첨가제의 필요성에 대한 인식이 확산되면서 국내산 사일리지용 첨가제를 개발하기 위한 연구가 이루어지고 있다.In recent years, as the awareness of necessity of additives for improving the quality of silage has spread, studies for developing additive for domestic silage have been conducted.
그러나, 사일리지는 가열공정을 거치지 않기 때문에 곰팡이 등과 같은 미생물들은 적당한 환경(온도, 영양 및 pH 조건)이 구비되면 번식이 용이하여 사일리지의 보관에 어려움을 겪고 있다. However, since the silage is not subjected to the heating process, the microorganisms such as fungi are difficult to store silage because they are easily breeded when the environment (temperature, nutrition and pH conditions) is provided.
또한, 사일리지 제조기술 부족과 유통, 보관 시 부주의로 곰팡이 등이 발생하면서 가축의 기호성이 감소되고 섭취량이 줄어드는 문제가 발생한다. 또한, 호기조건에 있는 사일리지는 영양적으로도 커다란 손실을 유발한다. In addition, lack of silage manufacturing technology and inadvertence of fungi during distribution and storage lead to decrease of palatability and decrease of intake of livestock. In addition, silage in aerobic conditions causes nutritionally large losses.
따라서, 사일리지에 발생하는 곰팡이를 억제함으로써 발효 효율 및 사료 저장성을 증진시킬 뿐만 아니라 사료의 영양성, 기호성 및 소화율도 향상시킬 수 있는 첨가제의 개발이 필요하다.Therefore, it is necessary to develop an additive capable of improving the nutritional, palatability and digestibility of the feed as well as enhancing the fermentation efficiency and feed retention by inhibiting molds generated in the silage.
(특허문헌 1) KR10-2011-0125108 A (Patent Document 1) KR10-2011-0125108 A
본 발명은 상기와 같은 기술적 과제를 해결하기 위하여, 신규 락토바실러스 플란타룸(Lactobacillus plantarum) K46 (KACC91758P) 균주를 제공한다. The present invention provides a novel Lactobacillus plantarum K46 (KACC91758P) strain to solve the above technical problem.
본 발명은 상기 균주를 포함하는 항균제 조성물을 제공한다.The present invention provides an antimicrobial composition comprising the strain.
그리고 본 발명의 상기 균주를 포함하는 항산화용 조성물을 또한 제공한다.The present invention also provides an antioxidant composition comprising the strain of the present invention.
또한 본 발명은 신규 락토바실러스 플란타룸(Lactobacillus plantarum) K46 (KACC91758P) 균주를 포함하는 식물체 사일리지 제조를 위한 미생물 첨가제를 제공한다. The present invention also provides a microbial additive for the production of plant silages comprising the novel Lactobacillus plantarum K46 (KACC91758P) strain.
뿐만 아니라 본 발명은 신규 락토바실러스 플란타룸(Lactobacillus plantarum) K46 (KACC91758P) 균주를 포함하는 식물체 사일리지 제조방법을 제공한다. In addition, the present invention provides a method for producing plant silage comprising the novel Lactobacillus plantarum K46 (KACC91758P) strain.
본 발명의 신규 균주는 항산화용 조성물 및 항균용 조성물로 제조될 수 있으며, 상기 항산화용 조성물 및/또는 항균용 조성물은 식품, 화장품, 의약품, 건강식품, 음료 등의 다양한 형태로 이용될 수 있다. The novel strain of the present invention can be prepared from a composition for antioxidation and a composition for antimicrobial use, and the antioxidant composition and / or the composition for antimicrobial use can be used in various forms such as foods, cosmetics, medicines, health foods and drinks.
뿐만 아니라 본 발명은 신규 락토바실러스 플란타룸(Lactobacillus plantarum) K46 (KACC91758P) 균주를 포함하는 사료 첨가제를 제공한다. In addition, the present invention provides a feed additive comprising a novel Lactobacillus plantarum K46 (KACC91758P) strain.
상기 기술적 과제를 달성하기 위하여, 본 발명은 신규 락토바실러스 플란타룸(Lactobacillus plantarum) K46 (KACC91758P) 균주를 제공한다. In order to achieve the above object, the present invention provides a novel Lactobacillus plantarum K46 (KACC91758P) strain.
상기 락토바실러스 플란타룸 K46 균주는 2012년 11월 08일자로 국립농업과학원 농업유전자자원센터에 기탁하였으며, 수탁번호 KACC91758P를 부여받았다.The Lactobacillus plantarum K46 strain was deposited with the National Institute of Agricultural Science and Technology, National Institute of Agricultural Science and Technology on November 8, 2012 and received the accession number KACC91758P.
곰팡이 등은 발효가 불량한 사일리지에서 다량 발견되고 발효가 양호하게 된 사일리지에서는 육안으로 판별하기 어려울 정도이기 때문에 사일리지 곰팡이 억제기능이 우수한 젖산균을 선발 및 분리하여 사일리지 보존성을 높이고자 하였다.Mildew were found in silage with poor fermentation and it was difficult to distinguish them by naked eyes in the silage where fermentation became good. Thus, lactic acid bacteria having excellent silage mold inhibiting ability were selected and separated to improve silage preservation.
본 발명의 발명자들은 락토바실러스 플란타룸 균주를 식품으로부터 분리하는 단계; 상기 분리한 락토바실러스 플란타룸 균주의 효소 활성능을 검정하는 단계; 상기 분리한 신규 미생물인 락토바실러스 플란타룸 균주의 동정 단계; 및 상기 분리된 락토바실러스 플란타룸 균주를 이용하여 프로바이오틱 특성을 검정하는 단계를 거쳐, 항균 활성, 항산화 활성이 우수한 신규 미생물인 락토바실러스 플란타룸 (Lactobacillus plantarum) K46 (KACC91758P) 균주를 얻었다.The inventors of the present invention have found that a step of isolating a Lactobacillus plantarum strain from a foodstuff; Assaying the enzymatic activity of the isolated Lactobacillus plantarum strain; Identifying the isolated new microorganism, Lactobacillus plantarum strain; And a step of assaying the probiotic characteristics using the isolated Lactobacillus plantarum strain, Lactobacillus plantarum K46 (KACC91758P) strain, which is a novel microorganism having excellent antimicrobial activity and antioxidative activity, was obtained .
본 발명의 실시예들에 따르면, 본 발명에 따른 락토바실러스 플란타룸 (Lactobacillus plantarum) K46 (KACC91758P) 균주는 부패 미생물의 활성을 저하시키고 생육을 억제시켜 항균 활성을 나타낼 수 있다.According to the embodiments of the present invention, the Lactobacillus plantarum K46 (KACC91758P) strain according to the present invention may exhibit antimicrobial activity by reducing the activity of the spoilage microorganism and inhibiting growth thereof.
상기와 같은 우수한 항균 효과로 인해 상기 균주는 항균용 조성물 제조에 이용할 수 있으며, 특히, 우수한 프로바이오틱 효과로 인해서 다양한 항균용 조성물을 포함하는 식품, 의약품, 화장품, 건강식품 등의 제조에 이용될 수 있다. Due to the excellent antibacterial effect as described above, the strain can be used in the production of antimicrobial compositions. In particular, the strains can be used for the production of foods, medicines, cosmetics, health foods and the like containing various antibacterial compositions due to their excellent probiotic effect .
본 발명의 항균용 조성물이 포함되는 식품, 의약품, 화장품, 건강식품 등의 제조는 업계에서 일반적으로 실시하는 방법을 통하여 제조될 수 있다.The manufacture of foods, medicines, cosmetics, health foods and the like containing the antimicrobial composition of the present invention can be manufactured by a method generally used in the industry.
본 발명의 발명자들은 본 발명의 신규 균주가 독성이 없으면서, 항균 활성이 뛰어나, 우수한 프로바이오틱 제제로 이용될 수 있다는 것을 실험을 통해서 밝혀내었다.The inventors of the present invention have found through experimentation that the novel strain of the present invention is excellent in antimicrobial activity without being toxic, and can be used as an excellent probiotic preparation.
본 발명의 균주는 바람직하게는 상기 우수한 항균 활성으로 인해 사일리지 제조시 저장성을 증진시킬 수 있고, 영양성분의 파괴를 예방할 수 있다.The strain of the present invention is preferably capable of enhancing storability during silage production due to the excellent antimicrobial activity and preventing destruction of nutritional ingredients.
또한, 부패 미생물등과 같은 원하지 않는 미생물에 의한 사일리지 풍미 감소 등을 예방하여, 가축의 기호성을 증진시킬 수 있는 추가 효과까지 얻을 수 있다. In addition, it is possible to prevent the decrease of the silage flavor caused by unwanted microorganisms such as spoilage microorganisms and the like, and to further enhance the palatability of the livestock.
본 발명의 또 다른 실시예들에 따르면, 본 발명의 신규 균주는 우수한 항산화 활성을 가지며, 본 발명의 균주를 포함하는 항산화용 조성물을 제공할 수 있다.According to still another embodiment of the present invention, the novel strain of the present invention has an excellent antioxidative activity and can provide a composition for antioxidation containing the strain of the present invention.
일반적으로 활성산소는 단백질의 SH기와 반응해서 효소의 활성을 잃게 하거나 가교결합의 형성, DNA, RNA, 효소 및 세포막을 구성하고 있는 불포화 지방산을 산화시켜 과산화지질을 형성하게 하는데, 과산화지질은 생체에 매우 유독하여 생체의 기능을 저하시켜서 결국에는 혈액순환장애, 피로, 심장병, 간장장애, 발암 등과 같은 질병의 원인이 되고 궁극적으로 노화의 원인이 된다.In general, reactive oxygen species react with SH groups of proteins to cause loss of activity of enzymes, oxidation of unsaturated fatty acids constituting crosslinks, DNA, RNA, enzymes and cell membranes to form lipid peroxides. It is very toxic and lowers the function of the living body and eventually causes diseases such as blood circulation disorder, fatigue, heart disease, hepatic disorder, carcinogen, etc., and ultimately causes aging.
본 발명의 발명자들은 본 발명의 락토바실러스 플란타룸 (Lactobacillus plantarum) K46 (KACC91758P) 균주가 항균 효과뿐만 아니라, 상기 활성산소의 억제 효과, 즉 항산화 효과가 우수함을 실험을 통해 확인하였다. The inventors of the present invention have confirmed through experiments that Lactobacillus plantarum K46 (KACC91758P) strain of the present invention has an antimicrobial effect as well as an excellent antioxidant effect.
상기와 같은 우수한 항산화 효과로 인해 상기 균주는 항산화용 조성물 제조에 이용할 수 있으며, 특히, 우수한 프로바이오틱 효과로 인해서 다양한 항산화용 조성물을 포함하는 식품, 의약품, 화장품, 건강식품 등의 제조에 이용될 수 있다. Due to the excellent antioxidative effect as described above, the strain can be used for the production of antioxidant compositions, and in particular, it can be used for the production of foods, medicines, cosmetics, health foods and the like containing various antioxidant compositions due to their excellent probiotic effect .
발명의 항산화용 조성물이 포함되는 식품, 의약품, 화장품, 건강식품 등의 제조는 업계에서 일반적으로 실시하는 방법을 통하여 제조될 수 있다.The manufacture of foods, medicines, cosmetics, health foods and the like containing the antioxidant composition of the present invention can be produced by a method generally used in the industry.
본 발명의 발명자들은 본 발명의 신규 균주가 독성이 없으면서, 항산화 활성이 뛰어나, 우수한 프로바이오틱 제제로 이용될 수 있다는 것을 실험을 통해서 밝혀내었다.The inventors of the present invention have found through experimentation that the novel strain of the present invention is excellent in antioxidative activity while being not toxic and can be used as an excellent probiotic preparation.
본 발명은 상기 락토바실러스 플란타룸 (Lactobacillus plantarum) K46 (KACC91758P) 균주를 포함하는 식물체 사일리지 발효용 미생물 첨가제를 또한 제공한다. The present invention also provides a microorganism additive for plant silage fermentation comprising the strain Lactobacillus plantarum K46 (KACC91758P).
상기 식물체 사일리지 발효용 미생물 첨가제를 첨가하는 대상이 되는 식물체는, 예를 들어 볏짚, 라이그라스(ryegrass), 총체보리, 총체벼, 호밀 또는 옥수수일 수 있으나 이에 제한되는 것은 아니며, 가축의 사료로 이용될 수 있는 식물체라면 모두 이용될 수 있다. The plant to which the microorganism additive for plant silage fermentation is added may be, for example, rice straw, ryegrass, whole barley, whole rice, rye or corn, but not limited to, Any plant that can be used can be used.
상기 식물체 사일리지 발효용 미생물 첨가제는 락토바실러스 플란타룸 (Lactobacillus plantarum) K46 (KACC91758P) 균주를 포함하는 배양원액, 또는 상기 배양원액의 희석액의 형태로 첨가할 수 있다.The microorganism additive for plant silage fermentation may be added in the form of a culture stock solution containing Lactobacillus plantarum K46 (KACC91758P) or a diluent of the culture stock solution.
또한 본 발명은 식물체에 락토바실러스 플란타룸(Lactobacillus plantarum) K46 (KACC91758P) 균주를 첨가하는 것을 특징으로 하는 식물체 사일리지 제조방법을 제공한다. The present invention also provides a method for producing plant silage, which comprises adding a strain of Lactobacillus plantarum K46 (KACC91758P) to a plant.
본 발명에 있어서, 상기 식물체 사일리지 제조방법은 당업계에서 사용되는 일반적인 방법으로서, 예를 들어 식물체의 발효를 위한 복수의 발효 단계들을 포함하는 것을 특징으로 한다. 상기 복수의 발효 단계들은, 예를 들어 혐기성균인 초산균의 발효 단계 및 이후 젖산균의 발효 단계 등을 포함할 수 있으며, 당업자에 의해 적절한 조건으로 수행될 수 있다.In the present invention, the method for producing plant silage is a general method used in the art, for example, including a plurality of fermentation steps for fermentation of a plant. The plurality of fermentation steps may include, for example, a fermentation step of anaerobic bacteria, such as a fermentation step, followed by fermentation of lactic acid bacteria, and the like, and may be carried out by those skilled in the art under appropriate conditions.
본 발명은 또한 상기 락토바실러스 플란타룸 (Lactobacillus plantarum) K46 (KACC91758P) 균주를 포함하는 사료 첨가제를 제공한다. The present invention also provides a feed additive comprising the Lactobacillus plantarum K46 (KACC91758P) strain.
본 발명의 사료 첨가제는 업계에서 일반적으로 이용되는 방법으로 제조될 수 있다. The feed additive of the present invention can be produced by a method commonly used in the art.
본 발명의 상기 신규 균주가 독성이 없으면서, 항균 활성이 뛰어나, 우수한 프로바이오틱 제제로 이용될 수 있고, 이러한 신규 균주는 우수한 항균 활성으로 인해 사료 첨가제 제조시 저장성을 증진시킬 수 있고, 영양성분의 파괴를 예방할 수 있다.The novel strain of the present invention is excellent in antimicrobial activity without being toxic and can be used as an excellent probiotic preparation. The novel strain has excellent antimicrobial activity and can improve storage stability in the production of feed additive, Destruction can be prevented.
본 발명에 따른 락토바실러스 플란타룸 K46은 우수한 항균 활성을 가진다. Lactobacillus plantarum K46 according to the present invention has excellent antibacterial activity.
또한, 본 발명에 따른 락토바실러스 플란타룸 K46은 항산화 효과가 우수하다. Lactobacillus plantarum K46 according to the present invention is also excellent in antioxidative effect.
본 발명에 따른 상기 균주를 이용하여 다양한 항균용 조성물 또는 항산화용 조성물을 제조할 수 있다. Various antimicrobial compositions or compositions for antioxidation can be prepared using the strains according to the present invention.
본 발명의 균주를 이용하여 제조된 식물체 사일리지는 가축의 소화율을 개선할 수 있고, 항균 효과가 우수하며, 풍미 개선으로 기호성을 향상시킬 수 있어 가축의 품질과 생산성을 높일 수 있다.The plant silage produced by using the strain of the present invention can improve the digestibility of livestock, improve antimicrobial effect, improve the taste by improving flavor, and improve the quality and productivity of livestock.
또한 상기 사일리지는 저장성이 향상되어 농가 소득 증대에 크게 기여할 수 있다.In addition, the silage can greatly contribute to the increase in the farm household income by improving the storage stability.
본 발명의 항균용 조성물 또는 항산화용 조성물은 독성이 없어 우수한 프로바이오틱 효과를 가지므로, 식품, 의약품, 화장품, 건강식품 등 다양한 형태로 활용될 수 있다. Since the antimicrobial composition or antioxidant composition of the present invention has no toxicity and has an excellent probiotic effect, it can be utilized in various forms such as foods, medicines, cosmetics, and health foods.
도 1은 식품 부패균에 대한 Lactobacillus 균주의 항곰팡이 활성을 나타낸 사진이다. A; A. fumigatus에 대한 것이며, B; G. moniliformis에 대한 것임.
도 2는 Lactobacillusplantarum K46의 Scanning Electron Microscope (SEM) 이미지이다.
도 3은 neighbor joining method를 이용하여 확립한, Lactobacillus plantarum K46 및 Lactobacillus 속에 해당하는 종들과의 관계를 보여주는, 16S rDNA 유전자 서열에 근거한 계통도이다.
도 4는 Lactobacillus plantarum K46으로부터 분리한 대사산물의 분리 및 스펙트럼 분석 프로파일이다.
a: 대사산물의 HPLC 분리;
b; 푸리에 변환 적외선 (FTIR);
c 및 d; 1H 핵자기 공명(NMR)및 13CNMR
도 5는 담즙 염 존재하에서 Lactobacillus plantarum K46의 세포 생존능력을 보여준다.
도 6은 Lactobacillus plantarum K46의 항산화 활성을 보여준다.
a; 과산화 수소 농도에 따른 저항성,
b; 히드록시 라디칼 소거능
c; DPPH 자유 라디칼 소거 효과1 is a photograph showing antifungal activity of Lactobacillus strain against food spoilage bacteria. A; A. for fumigatus, B for; For G. moniliformis .
Fig. 2 is a graph showing the activity of Lactobacillus plantarum This is a Scanning Electron Microscope (SEM) image of the K46.
Fig. 3 is a schematic diagram based on a 16S rDNA gene sequence showing the relationship with Lactobacillus plantarum K46 and Lactobacillus species established using the neighbor joining method.
Figure 4 shows that Lactobacillus plantarum Lt; RTI ID = 0.0 > K46 < / RTI >
a: HPLC separation of the metabolites;
b; Fourier Transform Infrared (FTIR);
c and d; 1 H nuclear magnetic resonance (NMR) and 13 CNMR
Figure 5 shows that Lactobacillus plantarum It shows the cell viability of K46.
Figure 6 shows that Lactobacillus plantarum K46 < / RTI >
a; Resistance to hydrogen peroxide concentration,
b; Hydroxy radical scavenging ability
c; DPPH free radical scavenging effect
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, embodiments of the present invention will be described in detail to facilitate understanding of the present invention. However, the embodiments according to the present invention can be modified into various other forms, and the scope of the present invention should not be construed as being limited to the following embodiments. Embodiments of the invention are provided to more fully describe the present invention to those skilled in the art.
균주의 분리 및 동정Isolation and Identification of Strain
균주의 분리 Isolation of strain
신규 균주를 분리하기 위하여, 발효된 배추, 무, 깻잎 및 시판되는 김치를 한국의 마켓(홈플러스)에서 구입하였다. 샘플을 살균한 증류수와 함께 혼합하고, heavy particulates를 제거하기 위하여 8,000 rpm 10분간 원심분리하였다. 적절히 희석후에, 상청액을 MRS agar에 골고루 펴주었다. 플레이트를 30°C에서 48 h 배양하고, Lactobacillus와 유사한 형태를 갖는 몇몇의 isolates를 선별하였다. 순수 분리 후, 선택된 신규 균주는 Lactobacillus sp.(K1에서 K54)로 번호를 지정하였고, 상기 균주들을 20% 글리세롤을 포함하는 MRS 배양액에서 -80 °C 로 보관하였다. 각 실험전 stock cultures는 18시간 동안 MRS 배양액에서 2배로 증식하였다.Fermented cabbage, radish, sesame leaf and commercially available kimchi were purchased from Korean market (Homeplus) to isolate the new strain. Samples were mixed with sterile distilled water and centrifuged at 8,000 rpm for 10 min to remove heavy particulates. After appropriate dilution, the supernatant was spread evenly on the MRS agar. Plates were incubated at 30 ° C for 48 h and several isolates with similar morphology to Lactobacillus were selected. After pure isolation, the selected new strains were numbered with Lactobacillus sp. (K1 to K54) and the strains were stored at -80 [deg.] C in MRS medium containing 20% glycerol. The stock cultures before each experiment were grown twice in the MRS culture for 18 hours.
곰팡이 균주 및 포자 현탁액(spore suspensions)의 준비Preparation of fungal strains and spore suspensions
흔히 식품 부패를 유발하는 곰팡이를 항균 분석을 위한 지표 미생물로 선별하였다. Aspergillus clavatus (KCTC 40071), A .fumigates(KCTC40080), A.niger(KCTC40280), Curvularialunata(KCTC40392), F. culmorum(KCTC42099), F.oxysporum(KCTC40051), Gibberellamoniliformis(KCTC44022), Penicilliumchrysogenum(KCTC40399) 및 P. roqueforti 은 대한민국 농촌진흥청 농업유전자원센터로부터 확보하였다. 이들을 포자가 형성될 때 까지 sabrous dextrose agar (SDA, Sigma)에서 30 °C에서 96 h 배양하였다. 포자는 그 다음 sterile saline water로 채집하고, 부유액을 포자 생산량 증가를 위해 Roux flask에서 SDA위에 펴주었다. 추가 실험을 위해 부유액의 최종 농도 107spores/mL를 20 °C에서 glycerol (10%, v/v)에서 보관하였다. Frequently, molds causing food spoilage were selected as indicator microorganisms for antimicrobial analysis. Aspergillus clavatus (KCTC 40071), A .fumigates (KCTC40080), A.niger (KCTC40280), Curvularialunata (KCTC40392), F. culmorum (KCTC42099), F.oxysporum (KCTC40051), Gibberellamoniliformis (KCTC44022), Penicilliumchrysogenum (KCTC40399) and P . roqueforti Was obtained from the Center for Agricultural Genetic Resources, Korea Rural Development Administration. They were cultured in Sabrous dextrose agar (SDA, Sigma) at 30 ° C for 96 h until spores were formed. The spores were then harvested with sterile saline water and spread over the SDA in a Roux flask to increase spore production. For further experiments, 10 7 spores / mL of the suspension at the final concentration was stored at 20 ° C in glycerol (10%, v / v).
항곰팡이Antifungal 활성 activation
실험 미생물의 저해 스펙트럼(inhibition spectrum)은 MRS agar 플레이트에서 Strom et al. (2002)에 기술되어진, diffusion method 및 overlay method 를 사용하여 측정하였으며, G.moniliformis 및 A. fumigatusas 를 확인을 위한 지표로 이용하였다. 간단히 말해, 상기 LAB는 MRS agar plates에서 2 cm streaks 형태로 자랐고 30°C에서 48 h 동안 micro aerobic 상태하에서 배양하였다. Plates는 반고체의 malt extract(1.0%)로 덮어씌웠으며, G. moniliformis 및 A. fumigatus을 104spores/mL로 균을 접종하고, 30°C에서 24 내지 72 h 시간 동안 호기성 조건에서 배양하였다. 억제의 Clear zones을 측정하였다. 16S rDNA 유전자 서열 분석을 통하여, 동정하기 위한 22개의 항곰팡이성 LAB를 선택하였고, antagonistic activity이 우수한 K46 균주를 선발하였다. The inhibition spectrum of the experimental microorganisms was determined on an MRS agar plate by Strom et al. (2002), using the diffusion method and the overlay method. G. moniliformis and A. fumigatus as were used as indicators for confirmation. Briefly, the LAB was grown in 2 cm streaks on MRS agar plates and cultured at 30 ° C for 48 h under micro aerobic conditions. Plates were covered with semi- solid malt extract (1.0%), and G. moniliformis And A. fumigatus 10 4 spores / mL, and cultured at 30 ° C for 24-72 h under aerobic conditions. Clear zones of inhibition were measured. Through the sequencing of 16S rDNA gene, we selected 22 antifungal LABs for identification and selected K46 strains with excellent antagonistic activity.
Lactobacillus Lactobacillus spsp .K46의 동정Identification of .K46
생화학적 실험Biochemical experiment
동정을 위한 접종원을 준비하기 위하여, 50 ml MRS 배지를 포함하는 flask를 접종하기 위해 glycerol stock vial을 사용하였다. 30°C에서 24 h 배양하였다. Lactobacillus sp. K46는 실험전 두배로 증식되었다. 표현형을 특징짓기 위하여 API 50 CHB (BioMerieux, Marcy l’Etoile, France) test kits를 이용하였다. 상기 API test strips를 manufacturer’s instructions에 따라 준비하였고 30oC에서 48 h 배양한 후에 기록하였다. To prepare inocula for identification, glycerol stock vials were used to inoculate flasks containing 50 ml MRS medium. And cultured at 30 ° C for 24 h. Lactobacillus sp. K46 was proliferated twice before the experiment.
Scanning electron microscopy (Scanning electron microscopy ( SEMSEM ) )
Lactobacillus sp. K46는 호기성 조건에서 기하급수적으로 자랐고, 10분간 8000 rpm으로 원심분리하였으며, 그 다음 펠렛을 0.1 M phosphate buffer saline (PBS), pH 7.2로 두번 세척하였다. 세포는 그 다음 glutaraldehyde (2.5%) 및 PBS (0.1 M)를 포함하는 일차 고착액에서 재-부유하였다. 단계적인 에탄올 (50, 60, 70, 80, 90, and 95%)로 탈수시킨 후, 고정된 세포는 hexamethyldisilazane로 두번 건조시켰다. 마지막으로, 탈수된 세포는 25 mA로 250 초 간 금으로 스퍼터(sputter) 코팅하고, 12 kV에서 SEM로 관찰한다 (JSM-6460 LV; JEOL, Tokyo, Japan). Lactobacillus sp. K46 grew exponentially under aerobic conditions and centrifuged at 8000 rpm for 10 min. The pellet was then washed twice with 0.1 M phosphate buffer saline (PBS), pH 7.2. The cells were then re-suspended in a primary fixative containing glutaraldehyde (2.5%) and PBS (0.1 M). After dehydration with staged ethanol (50, 60, 70, 80, 90, and 95%), the fixed cells were dried twice with hexamethyldisilazane. Finally, dehydrated cells are sputter coated with gold for 25 seconds at 25 mA and observed with SEM at 12 kV (JSM-6460 LV; JEOL, Tokyo, Japan).
항균제 감수성(antibiotic sensitivity) 및 저항성 패턴 결정Determination of antibiotic sensitivity and resistance pattern
Lactobacillus sp. K46의 항균제 감수성 및 저항성을 Arasu et al. (2013)에 나타난 disc diffusion method를 이용하여 분석하였다. 간단히 말해, 세포들은 MRS 배지에서 30°C에서 24 h 동안 키워 준비하였다. 108CFU/mL 세포를 포함하는 부유액의 test cultures (100 )를 단단해진 배지의 표면에 도말하고 10분간 건조시켰다. 다른 항균제가 로딩된 디스크들은 배지의 표면에 두고, 항균제들의 확산을 위해서 실온에서 30분간 방치하였다. 배양 후, 미생물들은 표준 항균 디스크 차트에의해 결정되는 inhibition zone의 지름에 따라, 항균제 감수성 또는 저항성으로 분류하였다. Lactobacillus sp. The antimicrobial susceptibility and resistance of K46 were determined by Arasu et al. (2013) using the disc diffusion method. Briefly, cells were grown in MRS medium at 30 ° C for 24 h. Test cultures (100) of suspensions containing 10 8 CFU / mL cells were plated on the surface of the hardened medium and dried for 10 minutes. Discs loaded with other antimicrobial agents were placed on the surface of the medium and allowed to stand at room temperature for 30 minutes to spread the antimicrobial agents. After incubation, the microorganisms were classified as susceptible or resistant to antimicrobial agents, depending on the diameter of the inhibition zone as determined by a standard antimicrobial disk chart.
16S 16S rDNA의rDNA PCRPCR 증폭 및 시퀀싱 Amplification and sequencing
16S ribosomal DNA 유전자는 다음의 프라이머들: 27 forward primer (5' AGA GTT TGA TCG TGG CTC AG 3') 및 1492 reverse primer (3' GGT TAC CTT GTT ACG ACT T 5')를 사용하여, Taq DNA polymerase로 PCR함으로써 K-46 균주의 genomic DNA로부터 증폭되었다. thermal cycling 조건은 다음과 같다: target DNA는 95 oC 로 10 min간 초기 변성한 후, 증폭을 위해 타겟 DNA의 95oC에서 10 min 변성 다음에 30 회 증폭, 95oC에서 2 min간 변성, 58oC에서 1 min간 프라이머 어닐링(annealing), 및 72oC에서 2 min간 프라이머 신장. 마지막 사이클에서, 반응 혼합물은 72oC에서 10분간 유지하고, 4oC로 냉각하였다. 증폭된 DNA는 agarose gel(1%(w/v) in TAE buffer 1x, 0.1ethidium bromide solution)에서 25분간 100V 및 400mA로 확인하였다. 상기 증폭된 PCR 산물은 QIAquickPCR purification Kit (Qiagen Ltd., Crawley, UK)로 정제하였다. 1500 base pairs를 Solgent Co. Ltd. (Seoul, Korea)에서 시퀀싱하였다. 얻어진 서열은 NCBI database에서 BLAST search를 수행하였다. evolutionary history는 Neighbor-Joining method를 이용하여 추측하였다. evolutionary 분석은 MEGA5로 하였다. The 16S ribosomal DNA gene was amplified by PCR using the following primers: 27 forward primer (5 'AGA GTT TGA TCG TGG CTC AG 3') and 1492 reverse primer (3 'GGT TAC CTT GTT ACG ACT T 5' And amplified from the genomic DNA of K-46 strain. Thermal cycling conditions are as follows: Target DNA is denatured at 95 ° C for 10 min, amplified for 30 min at 95 ° C for 10 min and denatured at 95 ° C for 2 min. , Primer annealing at 58 ° C for 1 min, and primer extension at 72 ° C for 2 min. In the last cycle, the reaction mixture was held at 72 ° C for 10 minutes and cooled to 4 ° C. The amplified DNA was confirmed by agarose gel (1% (w / v) in TAE buffer 1x, 0.1ethidium bromide solution) at 100V and 400mA for 25 minutes. The amplified PCR product was purified with a QIAquick PCR purification kit (Qiagen Ltd., Crawley, UK). 1500 base pairs to Solgent Co. Ltd. (Seoul, Korea). The obtained sequence was subjected to a BLAST search in the NCBI database. Evolutionary history was estimated using Neighbor-Joining method. The evolutionary analysis was done with MEGA5.
*항곰팡이성 대사산물의 대량 생산 및 추출 * Antifungal Mass production and extraction of metabolites
Lactobacillus sp. K46 5% glucose를 함유하는 3.5 L MRS 배지를 포함하는 살균된 Erlen mayer 플라스크에서 3일간 30°C에서 배양하였다. 발효 사이클의 마지막에 culture 배양액을 여과하고, 상청액은 8000 rpm에서 15분간 원심분리하였다. 전체 10 L 배양액을 수집하고 상청액은 에틸 아세테이트 (1:3 ratio)로 추출하였다. 용매상(solvent phase)은 항균성 생물검정을 위한 천연그대로의 추출물을 얻기 위하여 각각 40°C 진공상태에서 농축시켰다. 에틸 아세테이트 추출물은 실리카겔 컬럼으로 정제하였고 다양한 fraction을 얻었다. 화합물의 순도는 5.0 mM H2SO4 를 이용해 60 oC에서 300 × 7.8 mm Aminex HPX-87H (Bio-Rad; Hercules, CA, USA) column을 통해 HPLC로 체크하였다. HPLC 분석은 220 nm 컬럼 파장에서 0.5 ml/min 의 유속으로 수행하였다. 다른 화합물들은 1H 핵자기공명(NMR)(300MHz)으로 스펙트럼 분석으로 확인하였다. 13C NMR spectrum은 AL-300JEOL instrument(75.45 MHz)로 측정하였고, 전기분무 이온화 질량 분광을 기록하였다. 적외선 스펙트럼은 KBr pellet method를 이용하여 기록하였다. Lactobacillus sp. K46 was cultured in sterile Erlen mayer flasks containing 3.5 L MRS media containing 5% glucose for 3 days at 30 ° C. The culture broth was filtered at the end of the fermentation cycle, and the supernatant was centrifuged at 8000 rpm for 15 minutes. Whole 10 L culture was collected and the supernatant was extracted with ethyl acetate (1: 3 ratio). The solvent phase was concentrated in a vacuum at 40 ° C to obtain an intact extract for antimicrobial bioassay. The ethyl acetate extract was purified by silica gel column and various fractions were obtained. The purity of the compounds was checked by HPLC using a column of Aminex HPX-87H (Bio-Rad; Hercules, Calif., USA) at 300 ° C 7.8 mm at 60 ° C with 5.0 mM H 2 SO 4 . HPLC analysis was performed at a flow rate of 0.5 ml / min at a 220 nm column wavelength. Other compounds were identified by spectral analysis with 1 H nuclear magnetic resonance (NMR) (300 MHz). The 13 C NMR spectrum was measured with an AL-300JEOL instrument (75.45 MHz) and the electrospray ionization mass spectrometry was recorded. Infrared spectra were recorded using the KBr pellet method.
항곰팡이Antifungal 활성 activation
항곰팡이 활성 및 최소 저지 농도(MIC)는 표준 참고 방법 (NCCLS, 1999)에 따라 수행하였다. 화합물은 2% dimethyl sulfoxide (DMSO)와 함께 물에 용해시켰다. 초기 테스트 농도는 단계적으로 두 배씩 희석하였다. 각각의 well은 104spore/mL 농도의 곰팡이를 포함하는 5 의 부유물로 접종하였다. 그 다음 항균제 케토코나졸(ketoconazol)을 양성 대조군으로 assay에 접종하였다. 플레이트는 30°C에서 24, 48 또는 72h 배양하였다. MIC는 시험 배양의 가시적인 성장을 저지하는 추출물의 최하 농도로 결정하였다. 항균 활성을 확인하기 위하여 실험은 3회 반복하였다. Antifungal activity and minimum inhibitory concentration (MIC) were performed according to the standard reference method (NCCLS, 1999). The compounds were dissolved in water with 2% dimethyl sulfoxide (DMSO). The initial test concentration was diluted stepwise by two-fold. Each well was inoculated with a suspension of 5 containing 10 4 spores / mL of fungi. The assay was then inoculated with the antibacterial agent ketoconazole as a positive control. Plates were incubated at 30 ° C for 24, 48 or 72 h. The MIC was determined as the lowest concentration of extract inhibiting the visible growth of the test cultures. The experiment was repeated 3 times to confirm the antimicrobial activity.
LactobacillusLactobacillus spsp . K46의 . Of K46 ProbioticProbiotic 특성 characteristic
낮은 low pH에 대한 내성Resistance to pH
낮은 pH에 대한 내성은 plate count method로 결정하였다. 간단히 말해, 활성 Lactobacillussp.K46는 MRS 배양액에서 키우고 pH 2.5로 염산(1.0 N)을 이용해 조절한 신선한 10 mL의 MRS 배양액에 접종되었으며(1%), 30°C로 3시간 배양하였다. 샘플에서 MRS agar plates에 적절히 희석액을 플레이팅하여 초기 박테리아 수 및 0 와 3 h 에 남아있는 세포 수를 각각 측정하였다. 상기 플레이트는 30°C 로 48 h 동안 배양하였고 자란 콜로니 수를 세었다. 실험은 3배수 실시하였다. Resistance to low pH was determined by the plate count method. Briefly, active Lactobacillus sp. K46 was inoculated (1%) in fresh 10 mL MRS culture grown in MRS medium and adjusted to pH 2.5 with hydrochloric acid (1.0 N) and incubated at 30 ° C for 3 h. MRS agar plates were appropriately plated with diluent to determine the number of early bacteria and the number of cells remaining at 0 and 3 h, respectively. The plate was incubated at 30 ° C for 48 h and the number of grown colonies was counted. The experiment was carried out three times.
담즙 내성Bile tolerance
두 개의 다른 담즙 염이 존재할 때 Lactobacillus sp. K46이 자라나는 능력을 약간의 변형을 가한 Vinderola 및 Reinheimer (2003) 방법에 따라 연구하였다. MRS-thio배양액 (0.2% 소듐 티오글리콜레이트가 공급된 MRS) 및 0.3% (w/v) Oxgall이 공급된 MRS-thio 배양액을 준비하고 Lactobacillus sp. K46 1% 부유액을 접종하였다. Oxgall이 없는 샘플은 대조군으로 이용하였다. 30°C에서 24시간 배양한 후에, 박테리아의 농도는 적절한 희석액으로 플레이팅한 MRS agar에서 생균수를 체크하였다. 실험은 3배수 실시하였다. When two different bile salts are present, Lactobacillus sp. The ability of the K46 to grow was studied according to the Vinderola and Reinheimer (2003) method with some modifications. MRS-thio medium supplemented with MRS-thio medium (MRS supplemented with 0.2% sodium thioglycolate) and 0.3% (w / v) Oxgall was prepared and cultured in Lactobacillus sp.
생체 Living body 아민Amine 생산 production
생체 아민의 생산은 Bover-Cid 및 Holzapfel (1999)에 기술된 방법으로 측정하였다. 간단히 말해, 리신, 티로신, 오르니틴 및 히스티딘을 각각 1.0% 첨가한 MRS agar 배지에 준비된 Lactobacillus sp. K46 cells 600 nm (OD600)에서 0.5 광학 농도로 접종하였다. 박테리아 성장을 향상시키기 위하여 Tween 80 (0.1%)을 배지에 포함시켰다. 브로모크레솔 퍼플(Bromocresol purple) (0.006%)을 pH indicator로 사용하였다. 선명한 보라색 halo의 형성은 아미노산 탈카복실화 효소가 존재함을 나타내는 positive 반응으로 생각된다. 아미노산을 공급하지 않은 배지는 음성 대조군으로 사용하였고 실험은 3배수 실시하였다. Production of biogenic amines was measured by the method described by Bover-Cid and Holzapfel (1999). Briefly, Lactobacillus sp., Prepared on MRS agar medium supplemented with 1.0% lysine, tyrosine, ornithine and histidine, respectively. K46 cells were inoculated at 600 nm (OD 600 ) at an optical density of 0.5. Tween 80 (0.1%) was included in the medium to enhance bacterial growth. Bromocresol purple (0.006%) was used as pH indicator. The formation of a clear purple halo is thought to be a positive reaction indicating the presence of an amino acid decarboxylase. The medium without the amino acid was used as a negative control, and the experiment was carried out three times.
효소 활성 스크리닝Enzyme activity screening
Lactobacillus sp. K46 에서 Alkaline phosphatise, Esterase, Esterase lipase, Lipase, Leucine arylamidase, Valine arylamidase, Cystine arylamidase, Trypsin, α-Chymotrypsin, Acid phosphatise, Naphthol-AS-Biphophohydrolase, α-Galactosidase, β-Galactosidase, β-Glucuronidase, α-Glucosidase, β-Glucosidase, N-Acetyl-β-glucosaminidase, α-Mannosidase 및 α-Fucosidase와 같은 각각의 효소 산물을 스크리닝하기 위하여 manufacturer’s instructions(BioMerieux)에 따라 kit method를 이용하여 어세이하였다. 0.5 OD600 로 준비된 세포는 10분간 8000 rpm으로 원심분리되고, 펠렛은 스크리닝을 위하여 살균된 증류수에서 정치하였다. LAB 균주들의 효소 활성은 30°C에서 4 h 배양한 후 각각의 well로 활성화된 세포 부유물 50 μL 을 옮겨서 측정하였다. 배양후 ZYMA 및 ZYM-B 시약 20 μL는 각각의 well로 추가하였고, 효소 활성을 측정하기 위하여 5분간 30°C에서 배양하였다. Lactobacillus sp. Α-Galactosidase, β-Glucuronidase, α-Glucuronidase, α-Chymotrypsin, Acid phosphatase, α-Chymotrypsin, Acid phosphatase, Esterase, Esterase lipase, Lipase, Leucine arylamidase, Valine arylamidase, Cystine arylamidase, Each enzyme product was screened using the kit method according to the manufacturer's instructions (BioMerieux), such as glucosidase, β-Glucosidase, N-Acetyl-β-glucosaminidase, α-Mannosidase and α-Fucosidase. Cells prepared at 0.5 OD 600 were centrifuged at 8000 rpm for 10 minutes, and the pellets were fixed in sterile distilled water for screening. Enzyme activity of LAB strains was measured by transferring 50 μL of activated cell suspension to each well after culturing at 30 ° C for 4 h. After incubation, 20 μL of ZYMA and ZYM-B reagents were added to each well and incubated at 30 ° C for 5 min to measure enzyme activity.
용혈성 활성(Hemolytic activity HaemolyticHaemolytic activity) activity)
용혈성 활성 측정을 위하여, 하트 인퓨전(heart infusion), 펩톤(peptone), 염화 나트륨(sodium chloride)를 포함하는 성분들과 agar를 물과 혼합하였고 오토클레이브에서 살균하였다. 살균한 후에, 약 40-50oC, 5%(w/v) 혈액을 배지에 첨가하였고 살균된 petriplates에 부었다. 굳어진 후, 준비된 Lactobacillus sp. K46 cells를 agar plates에 도말하였고, 30°C에서 48시간 배양하였다(Maragkoudakis et al. 2006).For hemolytic activity measurements, the components including heart infusion, peptone, sodium chloride and agar were mixed with water and sterilized in an autoclave. After sterilization, approximately 40-50 ° C, 5% (w / v) blood was added to the medium and poured into sterile petriplates. After hardening, the prepared Lactobacillus sp. K46 cells were plated on agar plates and cultured at 30 ° C for 48 h (Maragkoudakis et al. 2006).
단백질 분해 활성 Proteolytic activity
단백질 분해 활성은 10% skim milk 에서 30°C로 42h시간 키운 Lactobacillus sp. K46로 측정하였다. 흡광도는 ELISA reader (Bio-Radad) (Citi et al. 1963)로 650 nm 에서 확인하였다. 결과는 검량선에 따라 milligrams/milliliter 티로신으로 표현하였다. Proteolytic activity was determined by incubating Lactobacillus sp. Strain grown in 10% skim milk at 30 ° C for 42h. K46. Absorbance was confirmed at 650 nm with an ELISA reader (Bio-Radad) (Citi et al. 1963). The results were expressed as milligrams / milliliter tyrosine according to the calibration curve.
세포 표면 소수성 측정Cell surface hydrophobicity measurement
세포 표면 소수성 어세이는 Lee et al. (2011)를 약간 변형한 방법으로 수행하였다. 간단히 말해, 준비된 세포를 8000 rpm 으로 10 min간 원심분리하였다. cells는 PBS (pH 7.0)로 두번 세척하였다. 현탁액의 1 mL는 OD580nm에서 흡광도를 측정하는데 사용되었다. 두번째 평가에서, 현탁액의 다른 1 mL는 동일한 부피의 n-헥사데칸 (Sigma, USA)에 추가되었고 vortex를 이용하여 2분간 혼합하였다. 상이 분리되도록 하기 위해서 30분간 실온에두었고, 가장 상층액 1 mL는 제거하고 OD580nm에서 흡광도를 측정하였다. 소수성 퍼센트는 다음과 같이 계산하였다:(OD580 reading 1- OD580 reading2/ OD580 reading 1) × 100=% hydrophobicity.Cell surface hydrophobicity assays are described in Lee et al. (2011) in a slightly modified manner. Briefly, the prepared cells were centrifuged at 8000 rpm for 10 min. Cells were washed twice with PBS (pH 7.0). 1 mL of the suspension was used to measure the absorbance at OD 580 nm. In the second evaluation, another 1 mL of the suspension was added to the same volume of n-hexadecane (Sigma, USA) and mixed for 2 minutes using a vortex. To allow separation of the phases, they were left at room temperature for 30 minutes, and 1 mL of the supernatant was removed and absorbance was measured at OD 580 nm. The hydrophobic percent was calculated as follows: (OD580 reading 1- OD580 reading2 / OD580 reading 1) x100 =% hydrophobicity.
LactobacillusLactobacillus spsp . K46의 . Of K46 In vitroIn vitro 항균 활성 Antimicrobial activity
과산화수소 저항성Hydrogen peroxide resistance
Buchmeier et al. (1997) 방법에 약간의 변형을 가하여 실시하였다. 간단히 말해, 0.3 OD600 nm의 Lactobacillussp.K46 를 orbital incubator shaker에서 30°C로, 0.2, 0.4, 0.6, 0.8 및 1.0 mM 과산화수소가 보충된 100 mL MRS 배양액을 포함하는 500 mL 삼각 플라스크에서 키웠다. cell 생육은 600 nm에서 분광광도법적으로 측정하였고, cell 생육의 증가는 광학밀도 (OD)증가에 따라 측정하였다. Buchmeier et al. (1997) method with some modifications. Briefly, Lactobacillus sp. K46 at 0.3 OD 600 nm was grown in a 500 mL Erlenmeyer flask containing 100 mL MRS medium supplemented with 0.2, 0.4, 0.6, 0.8 and 1.0 mM hydrogen peroxide at 30 ° C in an orbital incubator shaker. Cell growth was measured spectrophotometrically at 600 nm, and the increase in cell growth was measured according to the increase in optical density (OD).
수산화 라디칼 소거 능력Hydroxyl radical scavenging ability
수산화 라디칼 소거능 측정은 Fenton reaction method (He et al. 2004)로 수행하였다. 간단히 말해, 1.0 mL의 브릴리언트 그린 (0.435 mM), 2.0 mL of FeSO4(0.5mM),1.5mLofH2O2(3.0%,w/v),and1.0,1.5,2.0를 포함하는 반응 혼합물과 Lactobacillus sp. K46 cells (109CFU/mL)2.5mL를 15분간 실온에서 배양하였고 흡광도는 624nm에서 측정하였다. 반응 혼합물의 흡광도 변화는 Lactobacillus sp. K46의 수산화 라디칼 소거 능력을 나타냈다.Hydroxyl radical scavenging activity was measured by the Fenton reaction method (He et al. 2004). Briefly, a reaction mixture containing 1.0 mL of brilliant green (0.435 mM), 2.0 mL of FeSO 4 (0.5 mM), 1.5 mL of H 2 O 2 (3.0%, w / v), and 1.0, Lactobacillus sp. 2.5 mL of K46 cells (10 9 CFU / mL) was incubated for 15 min at room temperature and absorbance was measured at 624 nm. The absorbance change of the reaction mixture was measured by Lactobacillus sp. K46 showed a hydroxyl radical scavenging ability.
소거능 (%) = [(A s-A 0)/ (A-A 0)]x100,(%) = [( A s - A 0 ) / ( A - A 0 )] x 100,
여기서 As 는 샘플이 존재할 때 흡광도를 의미하고, A 0 는 샘플이 없는 대조군의 흡광도이며, A 는 샘플 및 펜톤반응(Fenton reaction system)이 없을 때 흡광도이다.Where A s refers to the absorbance when the sample is present, A 0 is the absorbance of the control without the sample, and A is the absorbance in the absence of the sample and the Fenton reaction system.
DPPHDPPH 자유 라디칼 Free radical 소거능Scatters
DPPH 라디칼-소거 능력은 약간의 변형을 가한 Li et al. (2012)에 따른 방법으로 측정하였다. 간단히 말해, 준비한 Lactobacillus sp. K46 cells (109CFU/mL)1.0,1.5,2.0및 2.5 mL은 1.0 ml 메탄올성 DPPH 라디칼 용액(0.05 mM)에 첨가하였다. 상기 혼합물은 강하게 혼합하고 30분간 암조건으로 실온에서 배양하였다. 대조군은 오로지 탈이온수 및 DPPH solution을 포함하였다. Blank는 오로지 메탄올 및 cell만을 포함하였다. resulting solution의 흡광도는 12000 rpm 으로 10 분간 원심분리한 후에, 517nm에서 세 번 측정하였다. The DPPH radical-scavenging ability was slightly modified by Li et al. (2012). Briefly, the prepared Lactobacillus sp. 1.0, 1.5, 2.0, and 2.5 mL of K46 cells (10 9 CFU / mL) were added to 1.0 mL methanolic DPPH radical solution (0.05 mM). The mixture was mixed vigorously and incubated at room temperature for 30 minutes under dark conditions. Controls included deionized water and DPPH solution only. Blank contained only methanol and cells. The absorbance of the resulting solution was measured three times at 517 nm after centrifugation at 12000 rpm for 10 min.
소거능 (%) = [1-(A sample-A blank)/A control]x100(%) = [1- ( A sample - A blank ) / A control ] x100
결과result
항곰팡이성Antifungal LactobacillusLactobacillus 균주의Strain 분리 detach
본 연구는 대한민국에서 시판되는 발효 식품으로부터 항곰팡이 특성을 갖는 LAB 균주의 분리 및 특성과 관련된 것이다. 54개의 추정되는 LAB 균주를 분리하고 MRS agar 배지 및 BCP 배지에서 성장하는 능력에 따라 분리 및 정제하였다. 모든 균주들은 다양한 식품 부패 곰팡이에 대한 항곰팡이 활성을 보기 위해 스크리닝하였다. A. fumigates 에 대한 우수한 항곰팡이 활성이 기록되었다. 54 LAB 균주들 중에서, 33 균주가 A. fumigates.에 대해서 활성을 나타내었으며, 16개의 LAB 균주들은 G. moniliformis 에 대해 활성을 갖는 것으로 나타났다(도 1 참조). This study relates to the isolation and characterization of LAB strains with antifungal properties from fermented foods marketed in Korea. Fifty - four putative LAB strains were isolated and isolated and purified according to their ability to grow on MRS agar medium and BCP medium. All strains were screened for antifungal activity against various food spoilage fungi. Excellent fungicidal activity against A. fumigates was noted. Of the 54 LAB strains, 33 strains were A. fumigates. , And 16 LAB strains were found to be active against G. moniliformis (see Figure 1).
Lactobacillus sp.K46는 대상 곰팡이들에 대해 더욱 우수한 활성을 나타냈고, 이 균주를 생화학적 및 생리적 특성, 16s rDNA 증폭 및 시퀀싱에 의해 동정하였다. 이 균주를 더 큰 스케일에서 배양하고 신규 생물활성 대사산물을 추출하고 특징을 분석하였다. Lactobacillus sp.K46의 in vitro 프로바이오틱 및 항산화 특성을 또한 결정하였다. Lactobacillus sp.K46 showed better activity against the target fungi, and this strain was identified by biochemical and physiological characteristics, 16s rDNA amplification and sequencing. The strain was cultured at a larger scale and new biologically active metabolites were extracted and characterized. The in vitro probiotic and antioxidant properties of Lactobacillus sp. K46 were also determined.
LactobacillusLactobacillus spsp .K46의 생화학적 특성Biochemical properties of .K46
Lactobacillus sp. K46로 지정한 새로운 박테리아들 발효된 깻잎 샘플에서 발견하였으며; 이는 식품 부패균에 대한 훌륭한 항곰팡이 활성을 보여주었다. Lactobacillus sp. K46는 그람 양성, 중온성, 카탈라아제 음성 그리고 둥근형태(0.70.9 넓이 및 2.03.2 길이)를 가지는 박테리아임을 생화학적 테스트에서 밝혔고, SEM 촬영 결과를 도 2에 나타내었다. 이러한 미세 구조 형태학적 특성은 균주 K46이 Lactobacillus속에 해당한다는 것을 강력히 나타내고 있다. 성장을 위한 최적의 pH및 온도는 6.0-7.0 및 30-37°C이다. Lactobacillussp.K46은 아밀레이즈, 프로테이즈 및젤라티네이즈 효소 생산 테스트에서 양성 결과를 보였다. 글루코스로부터 CO2를 생산하지 않으나, 글루코네이트로부터 가스를 생산하였다. API 50 CHB 마이크로 테스트에서 나타난 생화학적 동정을 실시하였다. Lactobacillussp.K46은 글루코스, 락토스, 람노스, 수크로스, 아라비노스, 프럭토스, 갈락토스, 및 소르보오스에서 잘 자랐다. 그러나, 이노시톨, 자일로스, 트레할로스, 멜리비오스. 글리세롤 또는 아라비톨에서는 잘 자라지 못하였다. 다양한 탄소원의 이용은 탄소원 동화의 다양한 패턴을 보여주었다. m-디아미노피멜릭산은 세포벽 가수분해물에서 관찰되었다. 생화학적 및 생리적 연구는 상기 균주가 Lactobacillus 속에 속한다는 것을 보여준다. Lactobacillus sp. New bacteria designated as K46 were found in a fermented sesame leaf sample; This showed excellent antifungal activity against food spoilage bacteria. Lactobacillus sp. K46 is a gram-positive, mesophilic, catalase-negative, and round-shaped (0.70.9 area and 2.03.2 length) bacterium that was biochemically tested and the results of SEM imaging are shown in FIG. These microstructural morphological characteristics strongly suggest that strain K46 corresponds to the genus Lactobacillus . The optimum pH and temperature for growth are 6.0-7.0 and 30-37 ° C. Lactobacillus sp.K46 showed positive results in the production of amylase, protease and gelatinase enzymes. Did not produce CO 2 from glucose, but produced gas from gluconate. Biochemical identification was performed in the
LactobacillusLactobacillus spsp .K46의 Of the .K46 항생물질Antibiotic 감수성 패턴 Susceptible pattern
항생물질 감수성 테스트는 disc diffusion method로 세균 감염에 가장 흔히 사용되는 항생물질들로 실험하였다. Lactobacillussp.K46 는 모든 시험대상이된 항생물질들에 대하여 유사한 감수성 패턴을 보였다(표 1 참조).The antimicrobial susceptibility test was carried out using the disc diffusion method as the most commonly used antibiotics for bacterial infection. Lactobacillus sp.K46 showed a similar susceptibility pattern to all tested antibiotics (see Table 1).
상기 표 1은 다양한 항생물질들에 대한 Lactobacillussp.K46의 감수성 패턴 비교를 나타낸 것이다.Table 1 above shows a comparison of the susceptibility patterns of Lactobacillus sp. K46 against various antibiotics.
상기 결과는 Lactobacillussp.K46는 대부분의 테스트한 항생물질들에 대해 감수성이면서, 병원성이 낮다는 것을 보여주고, 아미노 글리코시드 억제제 토브라마이신, 플루로퀴놀린 억제제 레보플록사신 및 스파프록사신 각각에 대해서 가장 높은 감수성을 보였다. 폴리케티드, 마크로리드 및 플로로퀴놀린 항생제: 테트라사이클린, 에리스로마이신 및 날리딕스산은 균주의 성장을 억제하지 않았다. 테트라사이클린 저항성은 전형적인 LAB 특징이다. 항생제에 대해 더 높은 감수성을 나타내는 것으로 보아 이 균주는 더욱 다양하게 적용할 수 있을 것으로 생각된다.The results show that Lactobacillus sp. K46 is susceptible to most tested antibiotics and has low virulence and is the most potent against the aminoglycoside inhibitor tobramycin, the fluloquinoline inhibitors levofloxacin and sparfocasin, respectively Respectively. Polyketide, macrolide and fluoroquinoline antibiotics: tetracycline, erythromycin and nalidixic acid did not inhibit the growth of the strain. Tetracycline resistance is a typical LAB characteristic. These strains are expected to be more versatile because they show a higher susceptibility to antibiotics.
16S 16S rDNArDNA 서열 분석 비교 Comparison of Sequence Analysis
22개의 LAB 균주들의 16S Rdna 유전자는 상동성 비교를 위해 완전히 시퀀싱하고 분석하였다. NCBI BLAST search program 분석 결과, Lactobacillus종에 높은 동일성(98%)을 가지는 것으로 나타났다. BLAST search program의 결과에 근거해, 균주 K3, K4, K7, K9, K10, K23, K33, K46 및 K54를 L. plantarum로 동정하였고, 균주 K8, K39, K48 및 K53은 L. pentoses 에 매우 유사한 것으로 나타났다(표 2 참조). The 16S Rdna gene of 22 LAB strains was fully sequenced and analyzed for homology comparison. Analysis of the NCBI BLAST search program showed that Lactobacillus species have high identity (98%). Based on the results of the BLAST search program, strains K3, K4, K7, K9, K10, K23, K33, K46 and K54 were identified as L. plantarum and strains K8, K39, K48 and K53 were very similar to L. pentoses (See Table 2).
상기 표 2를 참조하면, 균주 K5는 Leuconostoc mesenteroides (100%)인 것으로 밝혀졌고, 균주 K21, K22, K30, K35 및 K42는 L. graminis와 유사성이 높았다. Referring to Table 2 above, strain K5 was transformed into Leuconostoc mesenteroides (100%), and strains K21, K22, K30, K35 and K42 were highly similar to L. graminis .
K46 균주의 서열 데이터는 L. plantarum와 높은 동일성을 보였다(100%). 계통학적 트리는 Neighbor-Joining method를 이용하여 완성하였다(도 3 참조). The percentage of replicate trees showed that the associated taxa clustered together in the boot strap test(1000replicates). 트리는 계통학적 트리를 이끌어내는데 사용되는 evolutionary 거리와 동일한 단위로 가지 길이를 그렸다. Evolutionary 거리는 Maximum Composite Likelihood method를 사용하여 컴퓨터로 측정하였고 사이트당 염기 치환의 수에 근거하여 나타내었다.Sequence data of strain K46 showed high identity with L. plantarum (100%). The phylogenetic tree was completed using the Neighbor-Joining method (see FIG. 3). The percentage of replicate trees showed that the associated taxa clustered together in the bootstrap test (1000replicates). The tree draws the branch length in the same unit as the evolutionary distance used to derive the phylogenetic tree. Evolutionary distances were measured by a computer using the Maximum Composite Likelihood method and expressed based on the number of base substitutions per site.
핵산 서열 및 L. Nucleic acid sequence and L. plantarumplantarum K46 기탁번호 K46 Accession number
L. plantarum K46의 16S rDNA 서열은 accession number KC430920으로 NCBI 핵산 서열 데이터베이스에 맡겨졌다. L. plantarum K46순수 배양은 국립농업과학원 농업유전자자원센터에 기탁하였으며, 수탁번호 KACC91758P를 받았다. L. plantarum The 16S rDNA sequence of K46 was assigned to the NCBI nucleic acid sequence database with accession number KC430920. L. plantarum K46 pure culture was deposited with the National Institute of Agricultural Science and Technology, National Institute of Agricultural Science and Technology, and received the accession number KACC91758P.
특징, 스펙트럼 분석 및 Features, spectrum analysis and 항곰팡이Antifungal 활성 activation
천연그대로의 에틸 아세테이트 추출물은 다른 fraction을 얻기 위하여, 각각 다음과 같은 비율: 0:100, 25:75, 50:50 및 75:25 로 메탄올 및 에틸 아세테이트로 재-추출하였다. fraction은 밀집되어 있었으며 TLC 및 bio-autography로 순도를 다시 측정하였다. fraction내에 있는 불순물을 제거하기 위하여 100% 메탄올로 세척하였으며, 활성 fraction은 순도 측정을 위하여 HPLC를 실시하였다(도 4 참조). 항생물질의 동종성은 항생물질이 단일 피크로 컬럼에서 나오는 사전 역상 HPLC에 의해 더욱 확인되었다. 동정한 화합물의 IR 및 NMR 스펙트라 데이터를 통해 잘 알려진 화합물 3-페닐 젖산와 화학 구조적으로 매우 유사도가 높다는 것을 확인하였다. 분리된 화합물의 항곰팡이 프로파일은 표 3에 나타냈다. The crude ethyl acetate extract was re-extracted with methanol and ethyl acetate at the following ratios: 0: 100, 25: 75, 50: 50 and 75:25, respectively, to obtain different fractions. The fractions were dense and the purity was again measured by TLC and bio-autography. The fraction was washed with 100% methanol to remove impurities in the fraction, and the active fraction was subjected to HPLC for purity measurement (see FIG. 4). Homogeneity of antibiotics was further confirmed by pre-reversed phase HPLC, where the antibiotics exited the column with a single peak. The IR and NMR spectra of the identified compounds show that the chemical structure is very similar to the well known compound 3-phenyl lactic acid. The antifungal profiles of the isolated compounds are shown in Table 3.
C:(Compound), S (Ketoconazole), fungal control reference.C: (Compound), S (ketoconazole), fungal control reference.
상기 표 3은 Lactobacillus plantarum K46로부터 얻은 화합물의 항곰팡이 활성을 나타낸 것이다.Table 3 shows the antifungal activity of the compound obtained from Lactobacillus plantarum K46.
상기 표 3에 나타난 바에 따르면, A. clacatus , A. oryzae , P. chrysogenum 및 P.roqueforti (MIC: 2.5 mg/mL)에 대해서는 적절한 활성을 보이고 있으나, A.fumigates, A. niger, C. lunata 및 G. Moniliformis (MIC: 5.0 mg/mL)에 대해서는 상대적으로 활성이 덜한 것으로 나타났다. According shown in Table 3, A. clacatus, A. oryzae, P. chrysogenum and P.roqueforti (MIC: 2.5 mg / mL ) , but show the suitable activity for, A.fumigates, A. niger, C. lunata And G. Moniliformis (MIC: 5.0 mg / mL).
L.L. plantarumplantarum K46의 Of K46 프로바이오틱Probiotic 특성 characteristic
위장에서 미생물의 생존 능력은 유익한 프로바이오틱 세균의 가장 중요한 특징 가운데 하나이다. 그러므로, 낮은 pH 및 담즘 염 환경에서 생존능력을 연구하였다. pH 3.0 및 4.0에서 L. plantarum K46의 생존력을 표 4에 나타냈다. The viability of microorganisms in the stomach is one of the most important features of beneficial probiotic bacteria. Therefore, survival ability was studied in a low pH and dibasic salt environment. At pH 3.0 and 4.0, L. plantarum The viability of K46 is shown in Table 4.
값은 3배수 실시하여 측정하였으며 ± 표준편차로 나타냈다;Values were measured by performing triplicate and were expressed as ± SD;
(+) 양성 활성 ; (-) 음성 활성(+) Positive activity; (-) negative activity
상기 표 4는 낮은 pH에서 Lactobacillus plantarum K46 의 생존 능력을 나타낸 것이다. Table 4 above shows the viability of Lactobacillus plantarum K46 at low pH.
*표 4에 나타난 바에 따르면, 세포 생존력은 pH3.0에서 점차 감소하였으며, pH4.0에서 균주는 더욱 안정적인 성장을 보였다. 담즙 염(Oxgall (0.3%) 및 sodium taurocholate (0.3%))이 존재할 때, 균주의 생존력은 도 3에 나타냈다. 도 3에 나타난 바에 따르면, 균주들은 소듐 타우로콜레이트(sodium taurocholate) 존재하에서는 잘 자라지만, oxgall에 대해서는 민감한 것으로 나타났다. 균주들은 agar의 용혈성에 대해서는 negative 결과를 보였고 독성이 없는 것을 알 수 있었다. 단백질 분해 활성은 0.073 mg/mL 티로신 유리로 결정하였다. 티로신에 의한 카르복시이탈효소 활성은 양성으로 나타났고, 높은 소수성을 보였다(100%). 루신 아릴아미다제(leucine arylamidase) 및 β-글루코시데이즈(β-glucosidase) 활성 수준을 약하게 변화시키는 것으로 나타났으나, 알칼리성 인산가수분해 효소(alkaline phosphatase), α-푸코시데이트(α-fucosidase) 또는 α-만노시데이즈(α-mannosidase) 활성 (표 5 참조)에 대한 양성 반응은 일어나지 않았다. * As shown in Table 4, the cell viability gradually decreased at pH 3.0, and the strain showed more stable growth at pH 4.0. When bile salts (Oxgall (0.3%) and sodium taurocholate (0.3%)) were present, the viability of the strain was shown in Fig. As shown in Fig. 3, the strains were well grown in the presence of sodium taurocholate, but sensitive to oxgall. The strains showed a negative result for the hemolytic activity of agar and no toxicity. Proteolytic activity was determined by 0.073 mg / mL tyrosine. The carboxydebitase activity by tyrosine was positive and showed high hydrophobicity (100%). Leucine arylamidase and? -Glucosidase activity levels, but it has been found that alkaline phosphatase,? -Fucosidase, Or no α-mannosidase activity (see Table 5).
상기 표 5는 Lactobacillus plantarum K46의 세포외적 효소 활성을 나타낸 것이다.Table 5 shows the extracellular enzymatic activity of Lactobacillus plantarum K46.
상기 표 5에 나타난 바에 따르면, 상기 균주는 프로바이오틱으로 사용하기에 안전한 것으로 생각된다. As shown in Table 5 above, the strain is considered safe for use as a probiotic.
항산화 활성 Antioxidant activity
과산화 수소Hydrogen peroxide 저항성 Resistance
L. plantarum K46의 생존능력에 과산화수소의 영향은 도 6a에 나타내었다. L. plantarum K46 균주는 대조군과 비교할 때 H2O2 농도에 따라 강력한 저항성을 나타내는 것으로 나타났다. 균주는 0.6-0.8 mM H2O2,에서는 견딜 수 있으나, 1.0 mM H2O2에서, 8 h 배양 후, 0.65 이하의 광학밀도를 가지며, 성장이 감소된다. L. plantarum The effect of hydrogen peroxide on the viability of K46 is shown in Figure 6a. L. plantarum K46 strains were significantly higher in H 2 O 2 And showed strong resistance depending on the concentration. The strain is able to withstand 0.6-0.8 mM H 2 O 2 , but after 1.0 h H 2 O 2 incubation for 8 h, it has an optical density of 0.65 or less and its growth is reduced.
하이드록시Hydroxy 라디칼 Radical 소거능Scatters
L. plantarum K46 의 하이드록시 소거 어세이 결과는 도 6b에 나타냈다. 상기 하이드록시 소거능은 세포 농도가 증가함에 따라 함께 증가하였다. 이러한 결과는 상기 균주가 세포 농도 109CFU/mL에서 2 mL당 43.53% 억제율로, 높은 하이드록시 라디칼 소거능이 있다는 것을 나타낸다. L. plantarum The results of the hydrolysis assay of K46 are shown in Figure 6b. The hydroxyserptive potency increased with increasing cell concentration. These results indicate that the strain has a high hydroxy radical scavenging ability with a 43.53% inhibition rate per 2 mL at a cell concentration of 10 < 9 > CFU / mL.
DPPHDPPH 자유 라디칼 Free radical 소거능Scatters
L. plantarum K46 메탄올 추출물은 109CFU/mL 세포 농도에서 2 ml에서 높은 라디칼 소거능(59.88%)을 보여주면서, DPPH 활성이 적정량 의존적인 억제를 보였다. 상기 결과는 도 6c에 나타냈다. L. plantarum The K46 methanol extract showed a high dose-dependent inhibition of DPPH activity, with a high radical scavenging activity (59.88%) at 2 ml at 10 9 CFU / mL cell concentration. The results are shown in Fig. 6C.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160019926A KR101655778B1 (en) | 2016-02-19 | 2016-02-19 | Lactobacillus plantarum K46 and composition comprising the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160019926A KR101655778B1 (en) | 2016-02-19 | 2016-02-19 | Lactobacillus plantarum K46 and composition comprising the same |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020130137772A Division KR20150055426A (en) | 2013-11-13 | 2013-11-13 | Lactobacillus plantarum K46 and composition comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20160023762A true KR20160023762A (en) | 2016-03-03 |
| KR101655778B1 KR101655778B1 (en) | 2016-09-09 |
Family
ID=55535553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020160019926A KR101655778B1 (en) | 2016-02-19 | 2016-02-19 | Lactobacillus plantarum K46 and composition comprising the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101655778B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220030842A (en) * | 2020-09-03 | 2022-03-11 | 대한민국(농촌진흥청장) | Lactobacillus plantarum kcc-47 strain and composition comprising the same |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110494551B (en) | 2017-01-31 | 2023-06-16 | 庆熙大学校产学协力团 | Novel lactic acid bacteria and use thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110125108A (en) * | 2010-05-12 | 2011-11-18 | 조선대학교산학협력단 | A novel compound and use thereof |
-
2016
- 2016-02-19 KR KR1020160019926A patent/KR101655778B1/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110125108A (en) * | 2010-05-12 | 2011-11-18 | 조선대학교산학협력단 | A novel compound and use thereof |
Non-Patent Citations (3)
| Title |
|---|
| Genbank Accession No.KC430920(2013.02.24.) * |
| Journal of Microbiology, Vol.115, pp.1172-1185(Epub.2013.08.28.)* * |
| Kor. J. Microbiol. Biotechnol., Vol.36, pp.276-284(2008.) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220030842A (en) * | 2020-09-03 | 2022-03-11 | 대한민국(농촌진흥청장) | Lactobacillus plantarum kcc-47 strain and composition comprising the same |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101655778B1 (en) | 2016-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101757623B1 (en) | Lactobacillus plantarum KCC-10 and composition comprising the same | |
| Arasu et al. | In vitro antifungal, probiotic and antioxidant properties of novel Lactobacillus plantarum K46 isolated from fermented sesame leaf | |
| Valan Arasu et al. | Isolation and characterization of antifungal compound from Lactobacillus plantarum KCC‐10 from forage silage with potential beneficial properties | |
| JP6709208B2 (en) | New Lactobacillus strain and its use | |
| KR101832387B1 (en) | Method for producing fermented korean cultivated wild ginseng with enhanced specific ginsenoside content using lactic acid bacteria | |
| KR101904164B1 (en) | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
| KR20130063253A (en) | The alcohol resistant strain of lactic acid bacteria, pediococcus acidilactici and its use | |
| KR101655774B1 (en) | Lactobacillus plantarum KCC-19 and composition comprising the same | |
| KR102675187B1 (en) | Lactobacillus plantarum KCC-24 and composition comprising the same | |
| KR101451810B1 (en) | Novel Strains of Lactobacillus plantarum K255 with High Productivity of Gamma-Aminobutyric Acid | |
| KR20170050527A (en) | Vegetable Lactobacillus plantarum DSR KF15 having Activities on Antimicrobial And Antifungal for keeping freshness and Use Thereof | |
| KR101655778B1 (en) | Lactobacillus plantarum K46 and composition comprising the same | |
| KR20190018204A (en) | Lactobacillus brevis WCP02 strain having high gastric acid tolerance and bile acid, and high GABA productivity, and probiotics and fermented food by using the same | |
| CN116855414B (en) | Bacillus belicus and application thereof in fermented bean products | |
| KR20160063024A (en) | Lactobacillus plantarum KCC-24 and composition comprising the same | |
| KR101485970B1 (en) | Novel Lactobacillus sp. AML 2-1 strain, a method of producing polyamines and Gamma-aminobutyric acid using Lactobacillus sp. AML 2-1 and use of polyamines and Gamma-aminobutyric acid | |
| KR100631857B1 (en) | -3 Lactobacillus Brevis OPK-3 Having a High Production Ability of Gamma-Aminobutyric Acid | |
| KR101548640B1 (en) | Novel Strains of Lactobacillus plantarum JA71 with Folic Acid Producing Ability | |
| CN116948884A (en) | Lactobacillus delbrueckii subspecies with high biofilm formation and strong stress resistance and application thereof | |
| CN111996146B (en) | Lactobacillus plantarum for high yield of phenyllactic acid and application thereof | |
| KR20030064462A (en) | Novel microorganism inhibiting the growth of harmful bacteria and microbial preparation containing same as an effective ingredient | |
| KR20170045190A (en) | Lactobacillus plantarum KCC-24 and composition comprising the same | |
| KR20140117188A (en) | Novel strains Lactobacillus plantarum K154 with high gamma-aminobutyric acid activity | |
| KR20150055426A (en) | Lactobacillus plantarum K46 and composition comprising the same | |
| KR20150055428A (en) | Lactobacillus plantarum KCC-19 and composition comprising the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |